This is the authors' abstract. We don't add key points for this paper.
The author questions the significance of calcineurin inhibitors in posttransplant kidney dysfunction. See rhetorical viewpoint by Chapman on page 693.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Arthur J. Matas (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: